consider, that you are not right. assured..
Lipitor. Classification. Therapeutic: lipid-lowering agents. Pharmacologic: Advise patient that these symptoms may represent drug-induced myopathy, and that. Lovastatin (Mevacor, Altocor) is a cholesterol-lowering statin drug used to inhibit the Other statins include simvastatin (Zocor), atorvastatin (Lipitor), fluvastatin. LIPITOR is an inhibitor of HMG-CoA reductase (statin) indicated as an .. drug, LIPITOR should be discontinued immediately and the patient apprised of the.
Davis drug guide lipitor - agree, theThe serious risk of myopathy or rhabdomyolysis should be weighed carefully versus the benefits of combined atorvastatin and ketoconazole therapy; there is no assurance that periodic monitoring of CK will prevent the occurrence of severe myopathy and renal damage. Darunavir; Cobicistat: Major Avoid concurrent administration of atorvastatin with cobicistat. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Oral drugs known to interact with cationic antacids, like statin cholesterol treatments, may also be bound by lanthanum carbonate. The incidence of nonfatal hemorrhagic stroke was significantly higher in the atorvastatin group 1. The serious risk of myopathy or rhabdomyolysis should be weighed carefully versus the benefits of combined atorvastatin and fluconazole therapy; there is no assurance that periodic monitoring of CK will prevent the occurrence of severe myopathy and renal damage. Clarithromycin: Major Do not exceed 20 mg per day of atorvastatin daily if coadministration with clarithromycin lisinopril and be avoided. Conjugated Estrogens; Bazedoxifene: Minor In clinical evaluation, atorvastatin 20 mg was given once with bazedoxifene 40 mg in 30 postmenopausal women. Rivaroxaban: Minor Coadministration of rivaroxaban and atorvastatin may result in increases in rivaroxaban exposure and guid increase bleeding risk. Intermittent hemodialysis Hemodialysis does not enhance the clearance of atorvastatin or its metabolites ; no dosage adjustment is needed. Atorvastatin is administered orally. Monitor cholesterol levels after adding bosentan therapy to evaluate the need for anti-lipemic dosage adjustment. Consider the benefits of breast-feeding, the risk of potential infant drug exposure, and the risk of an untreated durg inadequately treated condition. CNS: dizziness, headache, insomnia, weakness. If a patient becomes pregnant while taking this drug, atorvastatin should be discontinued immediately and the patient should be apprised of the potential hazard to the fetus. The possibility of reduced anti-lipemic efficacy should guidde considered. If pharmacotherapy is necessary in the nursing mother, a nonabsorbable resin such as cholestyramine, colesevelam, or colestipol should be considered. Ritonavir: Major Use caution and the lowest atorvastatin dose necessary if atorvastatin must be coadministered with ritonavir.
About The Author